Correction to: A pattern learning-based method for temporal expression extraction and normalization from multi-lingual heterogeneous clinical texts.

After publication of the original article [1] it was noted that the captions relating to Figs. 2 and 3 had been interchanged.

A pattern learning-based method for temporal expression extraction and normalization from multi-lingual heterogeneous clinical texts.

BACKGROUND: Temporal expression extraction and normalization is a fundamental and essential step in clinical text processing and analyzing. Though a variety of commonly used NLP tools are available for medical temporal information extraction, few work is satisfactory for multi-lingual heterogeneous clinical texts. METHODS: A novel method called TEER is proposed for both multi-lingual temporal expression extraction and normalization from various types of narrative clinical texts including clinical data requests, clinical notes, and clinical trial summaries. TEER is characterized as temporal feature summarization, heuristic rule generation, and automatic pattern learning. By representing a temporal expression as a triple , TEER identifies temporal mentions M, assigns type attributes A to M, and normalizes the values of M into formal representations N. RESULTS: Based on two heterogeneous clinical text datasets: 400 actual clinical requests in English and 1459 clinical discharge summaries in Chinese. TEER was compared with six state-of-the-art baselines. The results showed that TEER achieved a precision of 0.948 and a recall of 0.877 on the English clinical requests, while a precision of 0.941 and a recall of 0.932 on the Chinese discharge summaries. CONCLUSIONS: An automated method TEER for multi-lingual temporal expression extraction was presented. Based on the two datasets containing heterogeneous clinical texts, the comparison results demonstrated the effectiveness of the TEER method in multi-lingual temporal expression extraction from heterogeneous narrative clinical texts.

Occurrence of congenital syphilis after maternal treatment with azithromycin during pregnancy.

OBJECTIVE: To evaluate the efficacy of azithromycin in preventing congenital syphilis. METHOD: Five pregnant women with syphilis who were allergic to penicillin were given azithromycin, 1 g daily orally or intravenously, in different hospitals. The duration of the therapy ranged from 1 day to 10 days. A second course of therapy was provided at 28 weeks gestation. The babies were given a physical examination and blood test for serum rapid plasma reagin test (RPR), treponema pallidum hemagglutination test (TPHA), and fluorescent treponemal antibody adsorption test (FTA-ABS-19-sIgM) within three months after birth. RESULTS: Five infants born to these mothers developed skin rashes. Four of the infants had hepatomegaly and one showed osteochondritis. The tests RPR, TPHA, and FTA-ABS-19-sIgM were positive. The RPR titers varied from 1:64 to 1:256 and the babies were diagnosed with congenital syphilis. They were successfully treated with penicillin. CONCLUSIONS: Successful therapy for syphilis during pregnancy demands maternal care as well as prevention or cure of congenital infection. The failure of azithromycin in preventing congenital syphilis in our report suggests that azithromycin should not be recommended as an alternative in treating syphilitic pregnant women or fetal syphilis.

A study evaluating ceftriaxone as a treatment agent for primary and secondary syphilis in pregnancy.

OBJECTIVES: To evaluate the efficacy of ceftriaxone in pregnant women who were diagnosed with early syphilis. STUDY: Eleven women with a history of penicillin allergy, positive skin test, but prior history of safe usage of cephalosporins were included. Ceftriaxone (250 mg) was given intramuscularly once daily for 7 and 10 days to patients with primary and secondary syphilis, respectively. A second course of therapy was provided at 28 weeks' gestation. The rapid plasma reagin test (RPR) was measured before and after therapy. The blood of neonates was also tested at delivery and during the follow-up period. RESULTS: The serum RPR titers of 11 mothers decreased fourfold, 3 months after treatment. Ten patients developed negative RPR results. The serum RPR was negative at delivery or 6 months after delivery in all neonates. CONCLUSIONS: Ceftriaxone may be considered as an alternative for treatment of early syphilis in pregnancy.